Groshen, Susan
University of Southern California
8 papers on CoChatORCID 0000-0001-9705-1012
Most cited papers
- Verified
A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan
Brandhorst, S., Choi, I. Y., Wei, M., Cheng, C. W., Sedrakyan, S., Navarrete, G., Dubeau, L., Yap, L. P., Park, R., Vinciguerra, M., et al. (2015) · Cell Metabolism
Dietary Effects on HealthGenetics, Aging, and Longevity in Model Organisms
Cited by 850
- Verified
Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease
Wei, M., Brandhorst, S., Shelehchi, M., Mirzaei, H., Cheng, C. W., Budniak, J., Groshen, S., Mack, W. J., Guen, E., Di Biase, S., et al. (2017) · Science Translational Medicine
Dietary Effects on HealthGenetics, Aging, and Longevity in Model Organisms
Cited by 553
- Verified
Molecular determinants of cetuximab efficacy.
Vallböhmer, D., Zhang, W., Gordon, M., Yang, D. Y., Yun, J., Press, O. A., Rhodes, K. E., Sherrod, A. E., Iqbal, S., Danenberg, K. D., et al. (2005) · Journal of Clinical Oncology
Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Cited by 234
- Verified
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells
Ara, T., Song, L., Shimada, H., Keshelava, N., Russell, H. V., Metelitsa, L. S., Groshen, S. G., Seeger, R. C., & DeClerck, Y. A. (2009) · Cancer Research
Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases
Cited by 175
- Verified
DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
LaBonte, M. J., Wilson, P. M., Fazzone, W., Groshen, S., Lenz, H.-J., & Ladner, R. D. (2009) · BMC Medical Genomics
Histone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation
Cited by 99
- Verified
Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial
Matthay, K. K., Weiss, B., Villablanca, J. G., Maris, J. M., Yanik, G. A., DuBois, S. G., Stubbs, J., Groshen, S., Tsao-Wei, D., Hawkins, R., et al. (2012) · Journal of Nuclear Medicine
Neuroblastoma Research and TreatmentsRadiopharmaceutical Chemistry and Applications
Cited by 67
- Verified
Thyroid and hepatic function after high‐dose 131I‐metaiodobenzylguanidine (131I‐MIBG) therapy for neuroblastoma
Quach, A., Ji, L., Mishra, V., Sznewajs, A., Veatch, J., Huberty, J., Franc, B., Sposto, R., Groshen, S., Wei, D., et al. (2011) · Pediatric Blood & Cancer
Neuroblastoma Research and TreatmentsRadiopharmaceutical Chemistry and Applications
Cited by 60
- Verified
A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu
Pullarkat, V., Deo, Y., Link, J., Spears, L., Marty, V., Curnow, R., Groshen, S., Gee, C., & Weber, J. S. (1999) · Cancer Immunology, Immunotherapy
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free